| |
|
|
|
Leap Therapeutics Inc.  
|
|
1.795 -0.015 (-0.01%) |
07-15 13:17 |
|
Open: |
1.84 |
Pre close: |
1.81 |
Target:
|
2.84 
|
|
High: |
1.8478 |
Low: |
1.75 |
Resistance:
|
2.43
2.84
|
|
Volume: |
564,070 |
Market Cap: |
101M |
Support:
|
1.76
1.46
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.88
|
MACD |
MACD(12,26):
|
-0.12 |
|
MA(20): |
2.05 |
Signal(12,26,9): |
-0.08 |
|
MA(100): |
2.08 |
Stochastic Oscillator |
%K(14,3):
|
1.86 |
|
MA(250): |
1.70 |
%D(3): |
6.14 |
|
Average Volume(K) |
3-Month: |
60579
|
52-Week |
High:
|
3.18 |
|
10-Days: |
62950 |
Low: |
0.57 |
|
RSI |
RSI(14):
|
34.81 |
Change(%): |
-13.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.620 |
Return on Equity (ttm) |
-180.0 |
Shares Out. (M) |
56.05 |
|
EPS Est. Current Year |
-3.160 |
Return on Assets (ttm) |
-70.4 |
Shares Float (M) |
21.26 |
|
EPS Est. Next Year |
-3.090 |
PEG Ratio |
0.00 |
% Held by Insiders |
20.06 |
|
EPS Est. Next Quarter |
-0.630 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
48.18 |
|
Forward EPS |
-1.470 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1430 |
|
Book Value (p.s.) |
0.500 |
EBITDA (p.s.) |
-0.550 |
P/E |
-1.09 |
|
Sales Per Share |
0.007 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.53 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-23.96 |
P/S |
263.81 |
|
Operating Margin |
-8238.67 |
Levered Free Cash Flow
(M) |
-14.16 |
P/CF |
-4.13 |
|
|
|
|
|
|
